These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26948076)

  • 1. A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis.
    Brunner PM; Khattri S; Garcet S; Finney R; Oliva M; Dutt R; Fuentes-Duculan J; Zheng X; Li X; Bonifacio KM; Kunjravia N; Coats I; Cueto I; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2016 Jul; 138(1):169-178. PubMed ID: 26948076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.
    Khattri S; Brunner PM; Garcet S; Finney R; Cohen SR; Oliva M; Dutt R; Fuentes-Duculan J; Zheng X; Li X; Bonifacio KM; Kunjravia N; Coats I; Cueto I; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    Exp Dermatol; 2017 Jan; 26(1):28-35. PubMed ID: 27304428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.
    Khattri S; Shemer A; Rozenblit M; Dhingra N; Czarnowicki T; Finney R; Gilleaudeau P; Sullivan-Whalen M; Zheng X; Xu H; Cardinale I; de Guzman Strong C; Gonzalez J; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2014 Jun; 133(6):1626-34. PubMed ID: 24786238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
    Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
    J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.
    Pavel AB; Song T; Kim HJ; Del Duca E; Krueger JG; Dubin C; Peng X; Xu H; Zhang N; Estrada YD; Denis L; Rao N; Gupta S; Zammit DJ; Bissonnette R; Guttman-Yassky E
    J Allergy Clin Immunol; 2019 Oct; 144(4):1011-1024. PubMed ID: 31356921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.
    Guttman-Yassky E; Ungar B; Malik K; Dickstein D; Suprun M; Estrada YD; Xu H; Peng X; Oliva M; Todd D; Labuda T; Suarez-Farinas M; Bissonnette R
    J Allergy Clin Immunol; 2017 Oct; 140(4):1032-1042.e13. PubMed ID: 28238742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.
    Guttman-Yassky E; Diaz A; Pavel AB; Fernandes M; Lefferdink R; Erickson T; Canter T; Rangel S; Peng X; Li R; Estrada Y; Xu H; Krueger JG; Paller AS
    JAMA Dermatol; 2019 Dec; 155(12):1358-1370. PubMed ID: 31596431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trial.
    Czarnowicki T; Dohlman AB; Malik K; Antonini D; Bissonnette R; Chan TC; Zhou L; Wen HC; Estrada Y; Xu H; Bryson C; Shen J; Lala D; Ma'ayan A; McGeehan G; Gregg R; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):631-640.e11. PubMed ID: 29567358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.
    He H; Del Duca E; Diaz A; Kim HJ; Gay-Mimbrera J; Zhang N; Wu J; Beaziz J; Estrada Y; Krueger JG; Pavel AB; Ruano J; Guttman-Yassky E
    J Allergy Clin Immunol; 2021 Apr; 147(4):1369-1380. PubMed ID: 33011244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
    Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
    J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
    Brunner PM; Pavel AB; Khattri S; Leonard A; Malik K; Rose S; Jim On S; Vekaria AS; Traidl-Hoffmann C; Singer GK; Baum D; Gilleaudeau P; Sullivan-Whalen M; Fuentes-Duculan J; Li X; Zheng X; Estrada Y; Garcet S; Wen HC; Gonzalez J; Coats I; Cueto I; Neumann AU; Lebwohl MG; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2019 Jan; 143(1):142-154. PubMed ID: 30121291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset pediatric atopic dermatitis is T
    Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
    J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis.
    Guttman-Yassky E; Pavel AB; Zhou L; Estrada YD; Zhang N; Xu H; Peng X; Wen HC; Govas P; Gudi G; Ca V; Fang H; Salhi Y; Back J; Reddy V; Bissonnette R; Maari C; Grossman F; Wolff G
    J Allergy Clin Immunol; 2019 Aug; 144(2):482-493.e7. PubMed ID: 30738171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis.
    Zhou L; Leonard A; Pavel AB; Malik K; Raja A; Glickman J; Estrada YD; Peng X; Del Duca E; Sanz-Cabanillas J; Ruano J; Xu H; Zhang N; Wen HC; Gonzalez J; Garcet S; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2019 Jul; 144(1):144-156. PubMed ID: 30685456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis.
    Guttman-Yassky E; Facheris P; Gomez-Arias PJ; Del Duca E; Da Rosa JC; Weidinger S; Bissonnette R; Armstrong AW; Seneschal J; Eyerich K; Estrada YD; Bose SN; Xu D; Chen A; Tatulych S; Güler E; Chan G; Page KM; Kerkmann U
    Allergy; 2024 May; 79(5):1258-1270. PubMed ID: 38108208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients.
    Lang CCV; Renert-Yuval Y; Del Duca E; Pavel AB; Wu J; Zhang N; Dubin C; Obi A; Chowdhoury M; Kim M; Estrada YD; Krueger JG; Kaderbhai H; Semango G; Schmid-Grendelmeier P; Brüggen MC; Masenga JE; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):334-341. PubMed ID: 33975024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults.
    Renert-Yuval Y; Del Duca E; Pavel AB; Fang M; Lefferdink R; Wu J; Diaz A; Estrada YD; Canter T; Zhang N; Wagner A; Chamlin S; Krueger JG; Guttman-Yassky E; Paller AS
    J Allergy Clin Immunol; 2021 Jul; 148(1):148-163. PubMed ID: 33453290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.
    Brunner PM; Suárez-Fariñas M; He H; Malik K; Wen HC; Gonzalez J; Chan TC; Estrada Y; Zheng X; Khattri S; Dattola A; Krueger JG; Guttman-Yassky E
    Sci Rep; 2017 Aug; 7(1):8707. PubMed ID: 28821884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.